|

Vincristine Sulfate Liposome Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Marqibo

Pipeline

Phase 2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Refractory Lymphoblastic Lymphoma1
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements1
  • Refractory Burkitt Lymphoma1
  • Refractory Burkitt Leukemia1
  • Refractory Acute Lymphoblastic Leukemia1

Houston, Texas1 trial

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.